Tesofensine Peptide: The 13% Weight Loss Compound the FDA Won’t Approve
Tesofensine produced 10-13% weight loss in clinical trials-comparable to GLP-1 agonists. So why isn’t it FDA approved? We break down the science, the safety data, and whether it’s actually worth sourcing. In 2008, researchers at NeuroSearch A/S noticed something unexpected. They were testing a compound called tesofensine as a potential Parkinson’s disease treatment. Patients in …